Boehringer Ingelheim and HealthPrize Partner to Launch New Support Program for People Treating COPD With SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray
People living with chronic obstructive pulmonary disease (COPD) can earn rewards for tracking medication use and learning more about COPD
Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news
More News: Chronic Obstructive Pulmonary | Learning | Research | Spiriva | Tiotropium | Universities & Medical Training